Emmaus Life Sciences to Webcast Live at Life Sciences Investor Forum on December 16th

TORRANCE, Calif.: TORRANCE, Calif., Dec. 9, 2021 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today announced that Yutaka Niihara, M.D., M.P.H., Chairman and Chief Executive Officer of Emmaus, will present live at VirtualInvestorConferences.com, at 12:30 pm...

Click to view original post